Treatment Intelligence

Find a medication strategy or warning

Educational support for licensed clinicians. Use it to find source-linked options, warnings, and review-needed drafts. Verify decisions against labels, guidelines, and clinical judgment.

Condition, medication, symptom, mechanism, strategy, interaction, or warning
Example searches

Start here

How to use this page

Feature guide
Advanced: Deep Research Mode Source-first draft for slower questions

Deep Research Mode

Source-first draft

For questions that need options, conflicting evidence, monitoring, and manual verification.

Safety checklist Click risk areas to search warnings and exception cases
Safety checklist Click a risk area to search for warnings and exception cases.

LLM-Powered Search

M5 Max source-grounded answer

Ready 0.0s

Ask a clinical strategy or safety question above. The answer is saved as review-needed and should be manually verified before use.

Evidence Pearls

Loading pearls...

Patient-agnostic med list scratchpad

Educational safety review only

Scratchpad warnings

No meds selected

Interaction Matrix

Derived from label safety profiles

Pharmacist interaction tree

Expert-reviewed logic required

Use the scratchpad medication list to walk through interaction severity, source quality, patient exception cases, monitoring, and escalation. This navigation aid stays review-needed until pharmacist experts approve the decision nodes.

Expert panel workflow

Once your interaction experts are active, they can use this area to approve severity rules, branch language, monitoring prompts, and exception criteria.

  • Osler: lead clinical pharmacist and panel chair
  • Sabin: drug information specialist and evidence librarian
  • Goodman: clinical pharmacologist for mechanism and special-population PK
  • Vogel: pharmacogenomics specialist for CPIC and phenoconversion

Decision path

No run yet

Medication Safety Profiles

FDA/openFDA/DailyMed label sections

Public interaction corpus

Public-source facts

Review Queue

AI and seed claims stay review-needed until approved